Felbamate Suspension
Product Images NDC 51672-4172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 51672-4172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Felbamate 01)

FDA Label Image

Principal Display Panel (237 mL Bottle Label)

Principal Display Panel (237 mL Bottle Label)
NDC 51672-4172-1 is a prescription drug, Felbamate, available in the form of 81 oz (237 mL) Oral Suspension USP with a strength of 600 mg/5 mL. Each five milliliter contains Felbamate. It is recommended to dispense the medication guide to each patient. The standard dosage should be consulted while prescribing. The suspension should be stored in a container and under controlled conditions of 20 - 25°C (68 - 77°F) room temperature. The drug is manufactured and supplied by Taro Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.